Company / Current Assets per Share
CRISPR Therapeutics AG Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$23.16
FY2025
5-year range
$23.16 / $32.71
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
#23 of 212
Health Care
What the data says
CRISPR Therapeutics AG's current assets per share of $23.16 is higher than 89% of companies in the Health Care sector (FY2025). Current Assets per Share has fluctuated over the past 10 years, ranging from $6.25 in FY2017 to $57.92 in FY2016.
Based on SEC 10-K filings.
23.16 in FY2025 with a 5-year CAGR of -3.9%. Top quartile in the Health Care sector.
Declined from $24.30 to $23.16 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
-82.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 4.3% year-over-year.
- Ranks #23 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.16 | -4.3% |
| FY2024 | $24.20 | -0.4% |
| FY2023 | $24.30 | +1.0% |
| FY2022 | $24.07 | -26.4% |
| FY2021 | $32.71 | +15.8% |
| FY2020 | $28.24 | +48.3% |
| FY2019 | $19.05 | +65.8% |
| FY2018 | $11.49 | +83.7% |
| FY2017 | $6.25 | -89.2% |
| FY2016 | $57.92 | +86.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026